Codiak BioSciences, Inc.
NASDAQ:CDAK
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CDAK's stock price target?
Not Available
CDAK doesn't have any price targets made by Wall Street professionals.
What is Codiak BioSciences, Inc.'s Revenue forecast?
Projected CAGR
-41%
The compound annual growth rate of Codiak BioSciences, Inc.'s revenue for the next 2 years is -41%.